Emyria Launches Global Partnership Program
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Emyria Ltd has announced the launch of its Empax Global Partnership Program, aimed at providing international drug sponsors access to its clinical delivery infrastructure for mental health treatments. This new services platform is designed to create a dual-revenue model, combining existing treatment programs with high-margin, sponsor-funded services. The program is already operational and has begun collaboration with Psyence Group, demonstrating its immediate commercial application. Emyria's established clinical delivery network is positioned to address the growing demand for complex mental health therapies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Emyria
- EMD Commences NSW Workforce Recruitment To Support Expansion
- Key Milestones Achieved for First Victorian Empax Clinic
- Appendix 4D and Half Year End Financial Report
- Medibank Expands Funding to Emyria's Victorian Clinic
- Emyria's PTSD Program Delivers Lasting Recovery
Later from Emyria
- March 2026 Quarterly Activities Report and Appendix 4C
- Emyria Extends National Expansion into New South Wales
- March Quarter Investor Video Presentation
- Emyria Activates First Victorian Empax Clinic
- TGA Update to Accelerate Empax Therapist Recruitment
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria